.png){kind=icon}
揭示心血管药物研发领域的新机遇
Beating cardiovascular disease requires a strategic, scientific approach; from tracking changing disease patterns in an aging population to developing cutting-edge approaches to disease management, it's no easy task. 因此，您需要一个值得信赖的、在小分子、设备治疗和生物制剂领域拥有丰富经验的合作伙伴，帮助您把握不断变化的市场格局。徕博科心血管专家的独特优势在于他们具备学术和行业经验，可为您提供富有远见的研究设计、预测性研究管理和卓越的运作服务。
Enable success by leveraging cardiology expertise and precision delivery
The primary reason for late-stage drug failure in cardiovascular trials is the inability to document improvement in outcomes.因此，我们会在临床前试验阶段就与您及早开始合作，设计出以结果为导向的计划，帮助最小化风险，最大化您的成功几率。
Get answers on safety earlier using our nonclinical cardiovascular safety assessment techniques and gain critical information for your “go/no-go” decision
Add value to your study through our experience in cardiac ultrasound, magnetic resonance imaging, nuclear scanning and computed tomography (CT) angiography by capitalizing on our team of physicians who currently serve, or have served, as academic and core imaging laboratory directors
Validate your drug’s safety and efficacy by proactively identifying biomarkers—assays, multicomponent panels or imaging-based—that are most predictive of risk or success
利用设计合理的试验展示心血管成果方面的实际改善，超越替代生物标记物的范畴。
Reach your clinical development goals faster with specialized design and conduct of Phase I–Phase IV trials across a wide range of small molecules, devices and biologics including genetic therapies, peptides, enzyme replacement and stem cells
We are all about outcomes
开展具有特定复杂性的大型心血管试验是一项重大挑战。研究者的兴趣和能否招募到合适的患者群体对成败起着决定性的作用。 To point you toward success, we have partnered with cardiovascular academic research organizations who provide both medical and scientific leadership as well as insight into investigator and site quality.上述合作关系，加上徕博科专有的Xcellerate®知识库——全球最大的实验场地选择和临床试验实验室数据库，将让您更快找到符合试验条件的患者，并节省宝贵的时间和资金。
试验启动后，我们将运用从以往200多项全球临床试验终点试验中吸取的成功经验，进一步帮您提高运作效率，缩短试验时间。
End-to-end cardiology solutions aligned with your needs
我们针对心血管药物研发提供一整套的全面服务。从先导药物优化到商业化，我们拥有帮助您管理药品研究的复杂性并转变结果的专业知识和相关资源。
